New Drug Approvals Archive
New Drug Approvals: October 2005
| October 17 | Flexbumin (Albumin (Human)) Solution Date of Approval: October 17, 2005 Company: Baxter Healthcare Corporation Treatment for Plasma Volume Expansion Flexbumin is the first human serum albumin preparation packaged in a flexible container (previously packaged in glass bottles). Flexbumin is indicated in hypovolemia, hypoalbuminemia due to inadequate reproduction, excessive catabolism, hemorrhage, major surgery or burns, and for use during cardiopulmonary bypass surgery. Flexbumin Baxter Healthcare Corporation - Treatment for Plasma Volume Expansion |
| October 28 | Arranon (nelarabine) Injection Date of Approval: October 28, 2005 Company: GlaxoSmithKline Treatment for Acute Lymphoblastic Leukemia, Lymphoma Arranon is a chemotherapy agent indicated for the treatment of adults and children with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. Arranon GlaxoSmithKline - Treatment for Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma |
| October 29 | Soltamox (tamoxifen) Oral Solution Company: Savient Pharmaceuticals, Inc. Treatment for Breast Cancer Soltamox Savient Pharmaceuticals, Inc. - Treatment for Breast Cancer |
New Drug Approvals Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec
